EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy

Maria Grazia Ceraolo, Marika Milan iD, Nicole Fratini, Raffaello Viganò iD, Salma Bousselmi, Andrea Soluri iD, Elisa Pesce iD, Pier Luigi Mauri iD, Giusy Ciuffreda, Elisa Landoni, Francesca Brambilla, Gianpietro Dotti und 4 weitere

International Journal of Molecular Sciences · 09.07.2025 · 26 (14) · 6590

DOI: 10.3390/ijms26146590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.07.2025. Verfasst von Maria Grazia Ceraolo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. Hauptthemen laut MEDLINE: Cardiomyopathies, Muscular Dystrophy, Duchenne, Extracellular Matrix, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Fondazione Regionale per la Ricerca Biomedica (Regione Lombardia), Duchenne Parent Project ONLUS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting fibrosis in Duchenne muscular dystrophy (DMD)-associated cardiomyopathy is a critical outstanding clinical issue, as cardiac failure remains a leading cause of death despite advances in supportive care. This study evaluates the therapeutic efficacy of CSPG4-targeted chimeric antigen receptor (CAR) T cells in reducing cardiac fibrosis and improving heart function in a preclinical model of the disease. DMD is a progressive genetic disorder characterized by degeneration of skeletal and cardiac muscle. Cardiomyopathy, driven by fibrosis and chronic inflammation, is a leading contributor to mortality in affected patients. Proteoglycans such as CSPG4, critical regulators of extracellular matrix dynamics, are markedly overexpressed in dystrophic hearts and promote pathological remodeling. Current treatments do not adequately target the fibrotic and inflammatory processes underlying cardiac dysfunction. CSPG4-specific CAR-T cells were engineered and administered to dystrophic mice. Therapeutic efficacy was assessed through histological, molecular, and echocardiographic analyses evaluating cardiac fibrosis, inflammation, innervation, and overall function. Treatment with CSPG4 CAR-T cells preserved myocardial integrity, improved cardiac performance, and reduced both fibrosis and inflammatory markers. The therapy also restored cardiac innervation, indicating a reversal of neural remodeling commonly seen in muscular dystrophy-related cardiomyopathy. CSPG4-targeted CAR-T therapy offers a novel, cell-based strategy to mitigate cardiac remodeling in dystrophic hearts. By addressing core fibrotic and inflammatory drivers of disease, this approach represents a significant advancement in the development of precision immune therapies for muscular dystrophies and cardiovascular conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesMuscular Dystrophy, DuchenneExtracellular MatrixReceptors, Chimeric AntigenT-LymphocytesProteoglycansAnimalsMiceFibrosisDisease Models, AnimalMyocardiumMice, Inbred mdxMaleHumans

Stichwörter der Autor:innen

Duchenne muscular dystrophycardiomyopathyextracellular matrixheart failureimmunotherapyinnervation

Substanzen

Receptors, Chimeric AntigenProteoglycans

Autor:innen und Institutionen

  • Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Department of Molecular Medicine, Sapienza University, Viale Regina Elena, 324, 00161 Rome, Italy.
  • Institute for Biomedical Technologies, National Research Council, Via Fratelli Cervi, 93, 20054 Segrate, Italy.
  • Ph.D. Program in Cellular and Molecular Biology, Department of Biology, University of Rome "Tor Vergata", Via della Ricerca Scientifica, 1, 00133 Rome, Italy.
  • Institute of Biochemistry and Cell Biology, National Research Council of Italy (IBBC-CNR), Via Ercole Ramarini, 32, 00015 Monterotondo, Italy.
  • Fondazione Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Via Francesco Sforza, 35, 20122 Milan, Italy.

ORCID-Profile: Marika Milan, Raffaello Viganò, Andrea Soluri, Elisa Pesce, Pier Luigi Mauri, Dario Di Silvestre, Claudia Bearzi

Förderung

  • Italian Ministry of Health
  • Fondazione Regionale per la Ricerca Biomedica (Regione Lombardia)
  • Duchenne Parent Project ONLUS
  • National Research Council

Zitieren

APA

Ceraolo, M. G., Milan, M., Fratini, N., Viganò, R., Bousselmi, S., Soluri, A., Pesce, E., Mauri, P. L., Ciuffreda, G., Landoni, E., Brambilla, F., Dotti, G., Di Silvestre, D., Maiullari, F., Bearzi, C., & Rizzi, R. (2025). CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy. International Journal of Molecular Sciences, 26(14), 6590. https://doi.org/10.3390/ijms26146590

Vancouver

Ceraolo MG, Milan M, Fratini N, Viganò R, Bousselmi S, Soluri A, et al. CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy. International Journal of Molecular Sciences. 2025;26(14):6590. doi:10.3390/ijms26146590

BibTeX
@article{Ceraolo2025,
  author = {Ceraolo, Maria Grazia and Milan, Marika and Fratini, Nicole and Viganò, Raffaello and Bousselmi, Salma and Soluri, Andrea and Pesce, Elisa and Mauri, Pier Luigi and Ciuffreda, Giusy and Landoni, Elisa and Brambilla, Francesca and Dotti, Gianpietro and Di Silvestre, Dario and Maiullari, Fabio and Bearzi, Claudia and Rizzi, Roberto},
  title = {CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6590},
  doi = {10.3390/ijms26146590}
}
Kostenlos starten →